The Royal College of General Practitioner’s President Dr Bastian Seidel criticised the regulation surrounding medicinal cannabis at a meeting organised by the charity United in Compassion. The meeting attended by a coalition of doctors, lawyers and researchers gathered to discuss how to support easier access to medicinal cannabis in Australia.
Speaking at the meeting Dr Seidel acknowledged the importance of the learning phase for both the profession and regulators in order to to get the introduction right and was optimistic for a nationally consistent regulatory framework, but commented that “what we have now is a basket case.”
Read the article here.
In conjunction with the HMRI and lead biomedical scientist Dr Matt Dun, we’re investigating the anticancer properties of our plant varieties. Dr Matt Dun shares his initial thoughts on the joint research project.
We’re thrilled to announce we have received our export licence from the Drug Control Section of the ODC (Office of Drug Control). We’re firmly on course to continue to lead the way and be the first medicinal cannabis company in Australia to export cannabis flower to the EU since export was legalised in 2018.
We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.LEARN ABOUT ANTG HERE >